Related Experiment Video
Updated: Aug 24, 2026

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
[Hepatopulmonary syndrome]
Banu Eriş Gülbay1, Mutlu Gülbay, Akin Kaya
1Ankara University Faculty of Medicine, Pulmonary Diseases, Ankara, Turkey.
Abstract:
Liver diseases affect lungs. Pulmonary vascular diseases are observed in hepatic diseases and portal hypertension have a wide spectrum that varies from intrapulmonary vascular dilatation to increased pulmonary vascular resistance with pulmonary hypertension. Hepatopulmonary syndrome is a syndrome characterized portal hypertension, intrapulmonary vascular dilatation and abnormal oxygenation (hypoxaemia). This review summarizes the clinicopathologic features, diagnostic criteria, and management of hepatopulmonary syndrome.
Related Concept Videos
Portal Hypertension
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Other Pulmonary Disorders
Pneumonia II: Pathophysiology

